51111838 Bortezomib

Definition

UNSPSC 51111838

This classification denotes a proteasome inhibitor with the molecular formula C19H25BN4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 69G8BD63PP, chemically known as boronic acid, (3-methyl-1-((1-oxo-3-phenyl-2-((pyrazinylcarbonyl)amino)propyl)amino)butyl)-, (s-(r*,s*))- but generally known as bortezomib, which bears US NIH Compound Identifier 93860. European Medicines Agency schedules Bortezomib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20020. The term BORTEZOMIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 17, No. 4, 2003, List 50). World Health Organization schedules bortezomib in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule bortezomib under HS 29339990 and SITC 51577. As of Q4 2014, BORTEZOMIB remains the US FDA Preferred Term for this commodity. Bortezomib bears US NLM identifiers UMLS ID C1176309 and NCI Concept Code C1851. SMILES: O=C(NC(CC(C)C)[B](O)O)C(NC(=O)C1NCCNC1)CC1CCCCC1.

Same parent

Under 51111800 · 55

51111802 Bicalutamide Commodity 51111803 Estramustine Commodity 51111805 Goserelin Commodity 51111807 Leuprolide Commodity 51111810 Testolactone Commodity 51111815 Triptorelin Commodity 51111820 Letrozole Commodity 51111824 Exemestane Commodity 51111828 Cyproterone Commodity 51111829 Abarelix Commodity 51111830 Abiraterone Commodity 51111831 Acolbifene Commodity 51111832 Aminoglutethimide Commodity 51111833 Axitinib Commodity 51111834 Bazedoxifene Commodity 51111835 Benorterone Commodity 51111837 Bifluranol Commodity 51111838 Bortezomib You are here 51111839 Calusterone Commodity 51111840 Cetrorelix Commodity 51111841 Cioteronel Commodity 51111842 Degarelix Commodity 51111843 Deslorelin Commodity 51111844 Fadrozole Commodity 51111845 Dromostanolone or drostanolone Commodity 51111846 Epitiostanol Commodity 51111847 Erbulozole Commodity 51111848 Formestane Commodity 51111849 Fosfestrol Commodity 51111850 Gonadorelin Commodity 51111851 Histrelin Commodity 51111853 Inocoterone Commodity 51111854 Nafarelin Commodity 51111855 Lanreotide Commodity 51111856 Lapatinib Commodity 51111857 Lasofoxifene Commodity 51111858 Liarozole Commodity 51111859 Mecasermin Commodity 51111860 Mitotane Commodity 51111861 Terfluranol Commodity 51111862 Nilotinib Commodity 51111863 Octreotide Commodity 51111866 Sulprostone Commodity 51111867 Zindoxifene Commodity 51111868 Terguride Commodity 51111869 Trilostane Commodity 51111870 Vapreotide Commodity 51111871 Vorozole Commodity 51111872 Zanoterone Commodity 51111873 Tamoxifen Commodity 51111874 Tamoxifen citrate Commodity 51111875 Anastrozole Commodity 51111876 Leuprorelin Commodity 51111877 Enzalutamide Commodity 51111878 Goserelin acetate Commodity

Activities that produce or sell this

KBLI · 8

Inherited from family 51110000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class